Mast cells in psoriasis: a therapeutic target?

  • Research type

    Research Study

  • Full title

    Mast cells in psoriasis: a therapeutic target?

  • IRAS ID

    223387

  • Contact name

    Silvia Bulfone-Paus

  • Contact email

    silvia.bulfone-paus@manchester.ac.uk

  • Sponsor organisation

    University of Manchester

  • Duration of Study in the UK

    1 years, 11 months, 31 days

  • Research summary

    Mast cells are immune cells found in the skin which, when activated, drive inflammatory processes such as those seen in psoriasis. In biopsies taken from the plaques of psoriasis patients we have seen increases in the number of mast cells and their activation compared to similar biopsies from unaffected individuals. Our preliminary results suggest that mast cells change position in psoriasis plaques, moving from blood vessels and re-locating to be closer to nerves and other immune cells. We also see that mast cells produce signals that attract other cells into psoriasis plaques to worsen the inflammation. Therefore, our research will investigate whether mast cells contribute to the development of psoriasis by communicating with and attracting other inflammatory cells to the skin plaques that are characteristic of psoriasis. The objective of our project is to investigate how skin mast cell functions change during plaque development and also how these functions are affected by systemic treatments that lead to the improvement of plaques. By identifying alterations in mast cell functions we hope to be able to develop new treatments for psoriasis

  • REC name

    North West - Greater Manchester West Research Ethics Committee

  • REC reference

    17/NW/0328

  • Date of REC Opinion

    9 Jun 2017

  • REC opinion

    Favourable Opinion